Suppressing Effects of Down-regulating DNMT1 and DNMT3b Expression on the Growth of Human Cholangiocarcinoma Cell Line

Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order t...

Full description

Saved in:
Bibliographic Details
Published inJournal of Huazhong University of Science and Technology. Medical sciences Vol. 28; no. 3; pp. 276 - 280
Main Author 左石 罗剑 刘民锋 徐立宁 董泾青 郭伟 邹声泉
Format Journal Article
LanguageEnglish
Published Heidelberg Huazhong University of Science and Technology 01.06.2008
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China%Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Subjects
Online AccessGet full text
ISSN1672-0733
1993-1352
DOI10.1007/s11596-008-0310-7

Cover

Abstract Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
AbstractList Summary Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
R3; Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will inhere their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and over-expression and/or increased activity of DNA methyltransferases are considered to be the main cause of promoter hypermethylation. In order to explore the roles of two methyltransferase members (DNMT1 and DNMT3b) in the cholangiocarcinoma tumorigenesis, antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene was constructed respectively, and were co-transfected into the human cholangiocarcinoma cell line QBC-939 to observe their biological effects on the cell growth and proliferation ability, apoptosis, cell cycle alteration, and the tumorigenesis ability in the subcutaneous tissue of nude mouse. The results demonstrated that co-transfection with antisense eukaryotic expression plasmid of DNMT1 and DNMT3b gene and single transfection with antisense eukaryotic expression plasmid of DNMT1 gene can suppress the growth and proliferation of QBC-939, block the cell cycle at G1 phase, increase the apoptosis rate, minimize the tumor size in the subcutaneous tissue of nude mouse. The suppressing biological effect of co-transfection is stronger than single transfection with antisense DNMT1. Meanwhile, single transfection with antisense eukaryotic expression plasmid of DNMT3b gene has no effects on the biological characteristics of QBC-939. This study suggests that DNMT1 gene plays a key role in DNA methylation and DNMT3b gene may act as an accessory to support its function in inactivation of tumor suppressor genes. Combination DNMT1 and DNMT3b will increase their biological effects and have the synergistic effect on suppressing the growth of human cholangiocarcinoma cell line QBC-939.
Author 左石 罗剑 刘民锋 徐立宁 董泾青 郭伟 邹声泉
AuthorAffiliation Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430030, China Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China
AuthorAffiliation_xml – name: Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China%Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Author_xml – sequence: 1
  fullname: 左石 罗剑 刘民锋 徐立宁 董泾青 郭伟 邹声泉
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18563322$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URD_gB3BBFodeUMAfiZ0c0XZpKy1woJwt25lks03srZ2w23-Pt1lA4lDLlkfy-8y8njlHJ847QOgtJR8pIfJTpLSoREZImRFOSSZfoDNaVTyjvGAnKRaSZURyforOY9wQUkjB8lfolJaF4JyxM_Trx7TdBoixcy1eNg3YMWLf4Cu_c1mAdur1eHi6-vb1jmLt6qeIG7zcz5h3OO1xDfg6-N24PsA306AdXqx9r13beauD7ZwfNF5A3-NV5-A1etnoPsKb432Bfn5Z3i1ustX369vF51Vmc1KMmYXK8LSMtDIX1NiagyyEKVllREEbKaTJhS5BkLwCKdKhWtrayBwkMTW_QB_mvDvtmmRGbfwUXKqoxs3jfb3fGwUs9Y9wQklSX87qbfAPE8RRDV20ybN24KeoRMV4XpRlEr47CiczQK22oRt0eFR_-poEchbY4GMM0CjbjamT3o1Bd72iRB0mqOYJquRAHSaoZCLpf-Tf5M8wbGZi0roWwr9vPge9PxZae9c-JE4Zbe-brgfFpCiJqDj_Dc5-t9M
CitedBy_id crossref_primary_10_1186_1756_9966_32_86
Cites_doi 10.1007/s00018-004-4201-1
10.1200/JCO.2004.07.151
10.1111/j.1349-7006.2004.tb03254.x
10.1182/blood.V100.8.2957
10.1038/ng1068
10.1182/blood.V97.5.1172
10.1038/nature02625
10.1038/416552a
10.1186/1476-4598-3-28
10.1093/nar/27.11.2291
10.1586/14737140.4.4.501
10.1093/carcin/23.7.1103
10.1128/MCB.16.8.4555
ClassificationCodes R3
ContentType Journal Article
Copyright Huazhong University of Science and Technology and Springer-Verlag GmbH 2008
Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
Copyright_xml – notice: Huazhong University of Science and Technology and Springer-Verlag GmbH 2008
– notice: Copyright © Wanfang Data Co. Ltd. All Rights Reserved.
DBID 2RA
92L
CQIGP
W91
~WA
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
2B.
4A8
92I
93N
PSX
TCJ
DOI 10.1007/s11596-008-0310-7
DatabaseName 维普期刊资源整合服务平台
中文科技期刊数据库-CALIS站点
中文科技期刊数据库-7.0平台
中文科技期刊数据库-医药卫生
中文科技期刊数据库- 镜像站点
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Wanfang Data Journals - Hong Kong
WANFANG Data Centre
Wanfang Data Journals
万方数据期刊 - 香港版
China Online Journals (COJ)
China Online Journals (COJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList

MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Suppressing Effects of Down-regulating DNMT1 and DNMT3b Expression on the Growth of Human Cholangiocarcinoma Cell Line
EISSN 1993-1352
EndPage 280
ExternalDocumentID tjykdxxb_e200803010
18563322
10_1007_s11596_008_0310_7
27680693
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: 国家高技术研究发展计划(863计划)
  funderid: (2002AA214061)
GroupedDBID -5E
-5G
-BR
-Y2
-~C
.86
.VR
06C
06D
0R~
0VY
1N0
29K
29~
2B.
2C~
2J2
2JN
2KG
2KM
2LR
2RA
2~H
30V
4.4
408
40D
40E
53G
5GY
5VS
6NX
8TC
8UJ
92F
92I
92L
95-
95.
95~
96X
AAAVM
AABHQ
AAJKR
AANXM
AARHV
AARTL
AAYIU
AAYQN
AAYTO
ABFTV
ABJOX
ABKCH
ABMNI
ABNWP
ABQBU
ABTMW
ACGFS
ACHXU
ACKNC
ACOMO
ACSNA
ACUDM
ADHIR
ADINQ
ADKPE
ADURQ
ADYFF
ADZKW
AEBTG
AEGNC
AEJHL
AEKMD
AEOHA
AEPYU
AETLH
AEXYK
AFWTZ
AFZKB
AGAYW
AGDGC
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHYZX
AIIXL
AJBLW
AJRNO
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
ARMRJ
AZFZN
B-.
BA0
BGNMA
CAG
CCEZO
CHBEP
CIEJG
COF
CQIGP
CS3
CSCUP
CW9
D-I
EBS
EJD
ESBYG
FA0
FEDTE
FNLPD
FRRFC
FWDCC
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GQ6
GQ7
H13
HF~
HG6
HMJXF
HRMNR
HVGLF
HZ~
IJ-
IPNFZ
IXD
I~X
I~Z
J-C
JBSCW
JUIAU
KOV
M4Y
MA-
N2Q
NDZJH
NQJWS
NU0
O9-
O93
O9I
O9J
P9S
PF0
QOR
QOS
R-E
R89
R9I
RIG
ROL
RPX
RSV
S..
S16
S1Z
S27
S37
S3B
SAP
SCL
SDH
SHX
SMD
SNE
SNX
SOJ
SPISZ
SZ9
SZN
T13
TCJ
TGQ
TSG
TT1
TUC
U2A
U9L
UG4
VC2
W48
W91
WK8
Z7U
Z82
Z8V
ZOVNA
~A9
~WA
ABJNI
ABQSL
DPUIP
AAYXX
ADHKG
AGQPQ
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
4A8
93N
PSX
ID FETCH-LOGICAL-c405t-ce9b3333b7c7461bcd3e756b829b651f767b46a8e6049e769e71a7cdb74e70bd3
IEDL.DBID AGYKE
ISSN 1672-0733
IngestDate Thu May 29 04:06:47 EDT 2025
Fri Sep 05 12:14:11 EDT 2025
Thu Apr 03 07:05:38 EDT 2025
Thu Apr 24 23:00:28 EDT 2025
Wed Oct 01 00:35:46 EDT 2025
Fri Feb 21 02:37:19 EST 2025
Thu Nov 24 20:29:56 EST 2022
IsPeerReviewed false
IsScholarly false
Issue 3
Keywords cholangiocarcinma
DNA methyltransferase 1
apoptosis
DNA methyltransferase 36
antisense
Language English
License http://www.springer.com/tdm
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c405t-ce9b3333b7c7461bcd3e756b829b651f767b46a8e6049e769e71a7cdb74e70bd3
Notes DNA methyltransferase 1; DNA methyltransferase 36; cholangiocarcinma; antisense; apoptosis
42-1679/R
cholangiocarcinma
DNA methyltransferase 1
apoptosis
DNA methyltransferase 36
antisense
R73
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 18563322
PQID 69234588
PQPubID 23479
PageCount 5
ParticipantIDs wanfang_journals_tjykdxxb_e200803010
proquest_miscellaneous_69234588
pubmed_primary_18563322
crossref_citationtrail_10_1007_s11596_008_0310_7
crossref_primary_10_1007_s11596_008_0310_7
springer_journals_10_1007_s11596_008_0310_7
chongqing_backfile_27680693
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-06-01
PublicationDateYYYYMMDD 2008-06-01
PublicationDate_xml – month: 06
  year: 2008
  text: 2008-06-01
  day: 01
PublicationDecade 2000
PublicationPlace Heidelberg
PublicationPlace_xml – name: Heidelberg
– name: China
PublicationSubtitle Medical Sciences
PublicationTitle Journal of Huazhong University of Science and Technology. Medical sciences
PublicationTitleAbbrev J. Huazhong Univ. Sci. Technol. [Med. Sci.]
PublicationTitleAlternate Journal of Zuazhong University of Science and Technology: Medical Edition
PublicationTitle_FL JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY(MEDICAL SCIENCE)
PublicationYear 2008
Publisher Huazhong University of Science and Technology
Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China%Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
Publisher_xml – name: Huazhong University of Science and Technology
– name: Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
– name: Department of Hepatobiliary Surgery, The Affiliated Hospital of Guiyang Medical College, Guiyang 550004, China%Department of General Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China
References Tang, Sun, Zou (CR5) 2004; 19
Mizuno, Chijiwa, Okamura (CR15) 2001; 97
Fang, Yang, Zhu (CR18) 2004; 117
Curtis, Goggins (CR12) 2004; 103
Ballestar, Esteller (CR3) 2002; 23
Xu, Yu, Zhang (CR11) 2004; 10
Lind, Thorstensen, Lovig (CR14) 2004; 3
Robertson, Uzvolgyi, Liang (CR16) 1999; 27
Tang, Sun, Zou (CR6) 2004; 33
Robert, Morin, Beaulieu (CR17) 2003; 33
Daskalakis, Nguyen, Nguyen (CR20) 2002; 100
Lu, Fang, Zhu (CR8) 2004; 24
Egger, Liang, Aparicio (CR2) 2004; 429
Rhee, Bachman, Park (CR9) 2002; 416
Vertino, Yen, Gao (CR7) 1996; 16
Das, Singal (CR1) 2004; 22
Leu, Rahmatpanah, Shi (CR10) 2003; 63
Hermann, Gowher, Jeltsch (CR4) 2004; 61
Tozawa, Tamura, Honda (CR13) 2004; 95
Brown, Plumb (CR19) 2004; 4
Y. W. Leu (310_CR10) 2003; 63
Q. B. Tang (310_CR6) 2004; 33
T. Tozawa (310_CR13) 2004; 95
A. Hermann (310_CR4) 2004; 61
G. E. Lind (310_CR14) 2004; 3
S. Mizuno (310_CR15) 2001; 97
K. D. Robertson (310_CR16) 1999; 27
P. M. Vertino (310_CR7) 1996; 16
J. Y. Fang (310_CR18) 2004; 117
P. M. Das (310_CR1) 2004; 22
C. D. Curtis (310_CR12) 2004; 103
M. F. Robert (310_CR17) 2003; 33
X. L. Xu (310_CR11) 2004; 10
E. Ballestar (310_CR3) 2002; 23
M. Daskalakis (310_CR20) 2002; 100
I. Rhee (310_CR9) 2002; 416
Q. B. Tang (310_CR5) 2004; 19
R. Brown (310_CR19) 2004; 4
G. Egger (310_CR2) 2004; 429
R. Lu (310_CR8) 2004; 24
References_xml – volume: 61
  start-page: 2571
  issue: 19–20
  year: 2004
  ident: CR4
  article-title: Biochemistry and biology of mammalian DNA methyltransferases
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-004-4201-1
– volume: 22
  start-page: 4632
  issue: 22
  year: 2004
  ident: CR1
  article-title: DNA methylation and cancer
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.07.151
– volume: 103
  start-page: 123
  year: 2004
  ident: CR12
  article-title: DNA methylation analysis in human cancer
  publication-title: Methods Mol Med
– volume: 63
  start-page: 6110
  issue: 19
  year: 2003
  ident: CR10
  article-title: Double RNA interference of DNMT3b and DNMT1 enhances DNA demethylation and gene reactivation
  publication-title: Cancer Res
– volume: 95
  start-page: 736
  issue: 9
  year: 2004
  ident: CR13
  article-title: Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2004.tb03254.x
– volume: 100
  start-page: 2957
  issue: 8
  year: 2002
  ident: CR20
  article-title: Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2′-deoxycytidine (decitabine) treatment
  publication-title: Blood
  doi: 10.1182/blood.V100.8.2957
– volume: 33
  start-page: 34
  issue: 1
  year: 2004
  ident: CR6
  article-title: Effects of 5-aza-2-deoxycytidine on the growth and apoptosis of bile duct cancer cell line
  publication-title: J Huazhong Univ Sci Tech (Health Sci)
– volume: 33
  start-page: 61
  issue: 1
  year: 2003
  ident: CR17
  article-title: DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells
  publication-title: Nat Genet
  doi: 10.1038/ng1068
– volume: 97
  start-page: 1172
  issue: 5
  year: 2001
  ident: CR15
  article-title: Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia
  publication-title: Blood
  doi: 10.1182/blood.V97.5.1172
– volume: 429
  start-page: 457
  issue: 6990
  year: 2004
  ident: CR2
  article-title: Epigenetics in human disease and prospects for epigenetic therapy
  publication-title: Nature
  doi: 10.1038/nature02625
– volume: 16
  start-page: 4555
  issue: 8
  year: 1996
  ident: CR7
  article-title: De novo methylation of CpG island sequences in human fibroblasts overexpressing DNA(cytosine-5)-methyltransferase
  publication-title: Mol Cell Biol
– volume: 19
  start-page: 295
  issue: 5
  year: 2004
  ident: CR5
  article-title: 5-aza-2-deoxycytidine inhibits the growth of bile duct cancer cell line and
  publication-title: Chin J Gen Surg
– volume: 24
  start-page: 67
  issue: 2
  year: 2004
  ident: CR8
  article-title: Effect of recombinant DNA methylferase 1 plasmid on the expression of tumor associated gene in human colon cancer cell line
  publication-title: Chin J Dig
– volume: 416
  start-page: 552
  issue: 6880
  year: 2002
  ident: CR9
  article-title: DNMT1 and DNMT3b cooperate to silence genes in human cancer cells
  publication-title: Nature
  doi: 10.1038/416552a
– volume: 3
  start-page: 28
  year: 2004
  ident: CR14
  article-title: A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-3-28
– volume: 10
  start-page: 3441
  issue: 23
  year: 2004
  ident: CR11
  publication-title: Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis
– volume: 27
  start-page: 2291
  issue: 11
  year: 1999
  ident: CR16
  article-title: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/27.11.2291
– volume: 4
  start-page: 501
  issue: 4
  year: 2004
  ident: CR19
  article-title: Demethylation of DNA by decitabine in cancer chemotherapy
  publication-title: Expert Rev Anticancer Ther
  doi: 10.1586/14737140.4.4.501
– volume: 23
  start-page: 1103
  issue: 7
  year: 2002
  ident: CR3
  article-title: The impact of chromatin in human cancer: linking DNA methylation to gene silencing
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/23.7.1103
– volume: 117
  start-page: 99
  issue: 1
  year: 2004
  ident: CR18
  article-title: 5-Aza-2′-deoxycitydine induces demethylation and up-regulates transcription of p16INK4A gene in human gastric cancer cell lines
  publication-title: Chin Med J (Engl)
– volume: 22
  start-page: 4632
  issue: 22
  year: 2004
  ident: 310_CR1
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2004.07.151
– volume: 19
  start-page: 295
  issue: 5
  year: 2004
  ident: 310_CR5
  publication-title: Chin J Gen Surg
– volume: 23
  start-page: 1103
  issue: 7
  year: 2002
  ident: 310_CR3
  publication-title: Carcinogenesis
  doi: 10.1093/carcin/23.7.1103
– volume: 33
  start-page: 61
  issue: 1
  year: 2003
  ident: 310_CR17
  publication-title: Nat Genet
  doi: 10.1038/ng1068
– volume: 100
  start-page: 2957
  issue: 8
  year: 2002
  ident: 310_CR20
  publication-title: Blood
  doi: 10.1182/blood.V100.8.2957
– volume: 16
  start-page: 4555
  issue: 8
  year: 1996
  ident: 310_CR7
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.16.8.4555
– volume: 10
  start-page: 3441
  issue: 23
  year: 2004
  ident: 310_CR11
  publication-title: Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis
– volume: 95
  start-page: 736
  issue: 9
  year: 2004
  ident: 310_CR13
  publication-title: Cancer Sci
  doi: 10.1111/j.1349-7006.2004.tb03254.x
– volume: 4
  start-page: 501
  issue: 4
  year: 2004
  ident: 310_CR19
  publication-title: Expert Rev Anticancer Ther
  doi: 10.1586/14737140.4.4.501
– volume: 24
  start-page: 67
  issue: 2
  year: 2004
  ident: 310_CR8
  publication-title: Chin J Dig
– volume: 61
  start-page: 2571
  issue: 19–20
  year: 2004
  ident: 310_CR4
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-004-4201-1
– volume: 117
  start-page: 99
  issue: 1
  year: 2004
  ident: 310_CR18
  publication-title: Chin Med J (Engl)
– volume: 97
  start-page: 1172
  issue: 5
  year: 2001
  ident: 310_CR15
  publication-title: Blood
  doi: 10.1182/blood.V97.5.1172
– volume: 33
  start-page: 34
  issue: 1
  year: 2004
  ident: 310_CR6
  publication-title: J Huazhong Univ Sci Tech (Health Sci)
– volume: 3
  start-page: 28
  year: 2004
  ident: 310_CR14
  publication-title: Mol Cancer
  doi: 10.1186/1476-4598-3-28
– volume: 63
  start-page: 6110
  issue: 19
  year: 2003
  ident: 310_CR10
  publication-title: Cancer Res
– volume: 416
  start-page: 552
  issue: 6880
  year: 2002
  ident: 310_CR9
  publication-title: Nature
  doi: 10.1038/416552a
– volume: 27
  start-page: 2291
  issue: 11
  year: 1999
  ident: 310_CR16
  publication-title: Nucleic Acids Res
  doi: 10.1093/nar/27.11.2291
– volume: 429
  start-page: 457
  issue: 6990
  year: 2004
  ident: 310_CR2
  publication-title: Nature
  doi: 10.1038/nature02625
– volume: 103
  start-page: 123
  year: 2004
  ident: 310_CR12
  publication-title: Methods Mol Med
SSID ssj0057624
Score 1.4411304
Snippet Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and...
Summary Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes,...
R3; Hypermethylation in the promoter region is an important epigenetic mechanism for the transcriptional repression of a number of cancer-associated genes, and...
SourceID wanfang
proquest
pubmed
crossref
springer
chongqing
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 276
SubjectTerms Animals
Apoptosis
Biliary Tract Neoplasms - metabolism
Cell Line, Tumor
Cell Proliferation
Cholangiocarcinoma - metabolism
DNA
DNA (Cytosine-5-)-Methyltransferase 1
DNA (Cytosine-5-)-Methyltransferases - biosynthesis
DNA (Cytosine-5-)-Methyltransferases - genetics
DNA Methyltransferase 3B
Down-Regulation
Gene Expression Regulation, Neoplastic
Genetic Vectors
Humans
Medicine
Medicine & Public Health
Mice
Mice, Nude
Neoplasm Transplantation
甲基转移酶
细胞凋亡
Title Suppressing Effects of Down-regulating DNMT1 and DNMT3b Expression on the Growth of Human Cholangiocarcinoma Cell Line
URI http://lib.cqvip.com/qk/85740A/20083/27680693.html
https://link.springer.com/article/10.1007/s11596-008-0310-7
https://www.ncbi.nlm.nih.gov/pubmed/18563322
https://www.proquest.com/docview/69234588
https://d.wanfangdata.com.cn/periodical/tjykdxxb-e200803010
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAVX
  databaseName: SpringerLINK - Czech Republic Consortium
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: AGYKE
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://link.springer.com
  providerName: Springer Nature
– providerCode: PRVAVX
  databaseName: SpringerLink Journals (ICM)
  customDbUrl:
  eissn: 1993-1352
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0057624
  issn: 1672-0733
  databaseCode: U2A
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://www.springerlink.com/journals/
  providerName: Springer Nature
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bb5RAFD6x28T4Uu8Wq3Ue-qShgR2YgceNtjaa9mk3qU-EuUDr6qC7rFn99Z4DQ7de0qQEEhJgJnM938e5ARxEUUkhUQy5fVgkKNbQkjKhTY2sFNco0bpon2fiZJZ8OE_PvR_3crB2H1SS3U69cXZDyYvsl9T1iElCuQXbKfGTEWxP3n_6eDRswIig-1y2QpJhJeeDMvN_hVBIhYvG1d-xwj9F0z9485qutPPwcVXp6mvC6Pg-TIdm9DYo88NVqw71r78iPN6ynQ9gx4NTNuln00O4Y90juHvq1e-P4QflAO0MZ13NvCUIaypmkMqHiz6rPT16d3Y6jVnpTHfHFbNrb2_rGJ6IOVmN9L-9oI-7LIGs49iuvkTRusDKmq8lI50CIxT8BGbHR9O3J6FP3BBqxH9tqG2uOB5KapmIWGnDrUyFysa5EmlcSSFVIsrMCuQnVgq84lJqo2RiZaQMfwoj1zi7C6zK80SZrNIx6QdNnps0NplOEi6UwTIC2LsaPxT8ek7hrIoxkqhI5DyAaBjRQvuY55R640uxidZMvV10uTixtwsZwOurT771AT9uevnVME0KXJbUL6WzzWpZCATO5AQcwLN-9mwKy1LBcRsN4M0w_oXfN5Y31XTgZ9zm5fbzz7lZr1VhyYiFuG30_FaF7sG93vyFfiq9gFG7WNmXiLFate_X1D5szcaT39bSG58
linkProvider Springer Nature
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Zb9NAEB5BKgEv3KWhQPehTyBXdtfetR8raAm0yVMqlaeV97ALgXVJHBT49cz4aMqhSrVsyZJ3Z7XnfOO5AHbDMKeQKJbcPhwKKM7SlrKBS6wsNDfI0ZponxMxOo0_niVnnR_3ord271WSzUm9dnZDzovSL6nrEZME8jZsYDNpPICNg_efjg_7AxgRdJvLVkgyrOS8V2b-jwiFVDivfPkdG_yTNf2DN6_oShsPH1_kvrzCjI4ewLTvRmuDMttb1nrP_PorwuMN-_kQ7nfglB20q-kR3HL-MdwZd-r3J_CDcoA2hrO-ZJ0lCKsKZlGUD-ZtVnv69G4ynkYs97Z545q5VWdv6xneiDlZieJ_fU6VmyyBrJGxffkZWescG6u-5Yx0CoxQ8FM4PTqcvh0FXeKGwCD-qwPjMs3x0tLIWETaWO5kInS6n2mRRIUUUsciT51A-cRJgU-US2O1jJ0MteWbMPCVd1vAiiyLtU0LE5F-0GaZTSKbmjjmQlukMYTty_lDxm9mFM5K7aMQFYqMDyHsZ1SZLuY5pd74qtbRmmm0VZOLE0dbySG8vqxy0Qb8uK7wTr9MFG5LGpfcu2q5UAKBMzkBD-FZu3rWxNJEcDxGh_Cmn3_VnRuL61ra7VbcunD95efMrlZaOTJiIdk2fH4jojtwdzQdn6iTD5PjbbjXmsLQD6YXMKjnS_cS8VatX3X76zesJh2n
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1La9wwEB7aFEIvpe-4aRsdcmoxsVe2ZB9D0yV9ZOkhC7kJ62GnTSqnu07Z_PvM2HI2pSVQY4PBlgQaS_N9nhfAbpJUlBLFUtiHQ4LiLC0pG7vcylpzgxqtz_Y5E4fz7PNJfhLqnC5Hb_fRJDnENFCWJt_tXdh6bx34hloYmTCZ7hGfxPI-PMhQVRP7mk_2x60YsfRQ1VZIcrHkfDRr_qsLSq5w2vrmFw79p5L6C3nespr2sT6-rnxzSy1NH8OjgCfZ_vABPIF7zj-FzaNgMX8Gv6lsZ-_r6hsWnDdYWzOL7DteDIXo6dHB7Og4ZZW3_R3XzK2Ci6xneCJMZA0y9u6UGveF_VhPi33zHbXhAgdrf1aMzACMgOtzmE8_Hn84jEOthdggZOti40rN8dDSyEyk2ljuZC50MSm1yNNaCqkzURVOIKVwUuCVVtJYLTMnE235C9jwrXdbwOqyzLQtapOSSc-Wpc1TW5gs40Jb7COC7ZuJRl1tzigDlZog70lEySNIxqlXJqQpp2oZ52qdYJkkp_rymSg5JSN4d9PkYsjRcdfLO6M8Fa4kmpfKu_ZyqQRiXYrbjeDlIOZ1Z0UuOO58Ebwf5a7CUl_eNdJu-DTWL3c_rs7saqWVI78ToqPJq__qdAc2vx1M1ddPsy_b8HBwXqFfQq9ho1tcujeIkDr9tl8F1x1-BSM
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Suppressing+effects+of+down-regulating+DNMT1+and+DNMT3b+expression+on+the+growth+of+human+cholangiocarcinoma+cell+line&rft.jtitle=Journal+of+Huazhong+University+of+Science+and+Technology.+Medical+sciences&rft.au=Zuo%2C+Shi&rft.au=Luo%2C+Jian&rft.au=Liu%2C+Minfeng&rft.au=Xu%2C+Lining&rft.date=2008-06-01&rft.issn=1672-0733&rft.volume=28&rft.issue=3&rft.spage=276&rft_id=info:doi/10.1007%2Fs11596-008-0310-7&rft_id=info%3Apmid%2F18563322&rft.externalDocID=18563322
thumbnail_s http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F85740A%2F85740A.jpg
http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fwww.wanfangdata.com.cn%2Fimages%2FPeriodicalImages%2Ftjykdxxb-e%2Ftjykdxxb-e.jpg